Maher J E, Wenstrom K D, Hauth J C, Meis P J
Department of Obstetrics and Gynecology, University of Alabama at Birmingham.
Obstet Gynecol. 1994 May;83(5 Pt 2):851-4.
Amnioinfusion is an intrapartum intervention with proven benefit in certain clinical situations. It is thought to be a safe treatment with few adverse effects.
Two cases of fatal amniotic fluid (AF) embolism occurred in women who were treated during labor with a saline amnioinfusion. In both cases, amnioinfusion was administered after finding thick meconium staining of the AF. In addition to the amnioinfusion, common factors in these cases and three previously reported AF embolisms associated with amnioinfusion are the presence of rapid labor, meconium-stained fluid, or both.
Amniotic fluid embolism is a rare cause of maternal morbidity and mortality. It is not known whether amnioinfusion increases the rate of its occurrence in laboring patients. No change in clinical practice is warranted on the basis of these reports; however, future reports must be examined so that any common factors can be identified.
羊膜腔灌注是一种产时干预措施,在某些临床情况下已证实具有益处。它被认为是一种安全的治疗方法,副作用很少。
两例致命性羊水栓塞发生在分娩时接受生理盐水羊膜腔灌注治疗的女性身上。在这两例病例中,均在发现羊水被胎粪严重污染后进行了羊膜腔灌注。除羊膜腔灌注外,这些病例以及之前报道的三例与羊膜腔灌注相关的羊水栓塞的共同因素是产程快速、羊水被胎粪污染或两者皆有。
羊水栓塞是孕产妇发病和死亡的罕见原因。尚不清楚羊膜腔灌注是否会增加分娩患者发生羊水栓塞的几率。基于这些报告,无需改变临床实践;然而,必须对未来的报告进行审查,以便识别任何共同因素。